Tango Therapeutics, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE4Tango Therapeutics, Inc.TNGXOct 5

   Tango Therapeutics, Inc. (TNGX) reports

   • Crystal Adam filed Form 4 on 2026-10-05.
   • Acquired 27,000 shares at $5.20.
   • Sold 26,400 shares at $24.45.

   Adam Crystal

2. ROUTINE4Tango Therapeutics, Inc.TNGXSep 24

   Jessica Newcomb, insider filing for TNGX

   Jessica Newcomb, reporting

3. ROUTINE144Tango Therapeutics, Inc.TNGXSep 22

   Jessica Newcomb, planned sale of TNGX shares

   Jessica Newcomb, reporting

4. ROUTINE4Tango Therapeutics, Inc.TNGXSep 3

   Adam Crystal, insider filing for TNGX

   Adam Crystal, reporting

5. ROUTINESCHEDULE 13G/ATango Therapeutics, Inc.TNGXAug 14

   2 13G filings

   Ownership stake disclosure by Nextech Crossover I GP S.a r.l. (amended)

   Show all 2

   • SCHEDULE 13G/AOwnership stake disclosure (amended)Aug 14
   • SCHEDULE 13G/AOwnership stake disclosure (amended)Aug 14

   Nextech Crossover I GP S.a r.l., filed by

6. ROUTINESCHEDULE 13GTango Therapeutics, Inc.TNGXAug 14

   Ownership stake disclosure by GOLDMAN SACHS GROUP INC

   GOLDMAN SACHS GROUP INC, filed by

7. ROUTINESCHEDULE 13G/ATango Therapeutics, Inc.TNGXAug 14

   Ownership stake disclosure by Woodline Partners LP (amended)

   Woodline Partners LP, filed by

8. ROUTINESCHEDULE 13G/ATango Therapeutics, Inc.TNGXAug 14

   Ownership stake disclosure by FARALLON CAPITAL MANAGEMENT, L.L.C. (amended)

   FARALLON CAPITAL MANAGEMENT, L.L.C., filed by

9. ROUTINESCHEDULE 13G/ATango Therapeutics, Inc.TNGXAug 12

   Ownership stake disclosure by Adage Capital Management, L.P. (amended)

   Adage Capital Management, L.P., filed by

10. ROUTINE8-KTango Therapeutics, Inc.TNGXAug 11

    Current report

11. ROUTINE424B5Tango Therapeutics, Inc.TNGXAug 11

    Securities offering

12. ROUTINE8-KTango Therapeutics, Inc.TNGXAug 11

    Current report

13. NOTABLE10-QTango Therapeutics, Inc.TNGXAug 11

    Quarterly report

14. ROUTINE8-K/ATango Therapeutics, Inc.TNGXAug 7

    Current report (amended)

15. ROUTINE8-KTango Therapeutics, Inc.TNGXAug 6

    Current report

16. ROUTINE4Tango Therapeutics, Inc.TNGXAug 5

    Adam Crystal, insider filing for TNGX

    Adam Crystal, reporting

17. ROUTINE144Tango Therapeutics, Inc.TNGXAug 3

    Adam Crystal, planned sale of TNGX shares

    Adam Crystal, reporting

18. ROUTINE4Tango Therapeutics, Inc.TNGXJul 2

    Adam Crystal, insider filing for TNGX

    Adam Crystal, reporting

19. ROUTINE4Tango Therapeutics, Inc.TNGXJun 23

    2 insider filings

    Robert Azelby, insider filing for TNGX

    Show all 2

    • 4Insider filing for TNGXJun 23
    • 3New insider at TNGXJun 23

    Robert Azelby, reporting

20. ROUTINE8-KTango Therapeutics, Inc.TNGXJun 23

    Current report

21. ROUTINE144Tango Therapeutics, Inc.TNGXJun 17

    Crossover I Scsp Nextech, planned sale of TNGX shares

    Crossover I Scsp Nextech, reporting

22. ROUTINE144Tango Therapeutics, Inc.TNGXJun 11

    Daniella Beckman, planned sale of TNGX shares

    Daniella Beckman, reporting

23. ROUTINE8-KTango Therapeutics, Inc.TNGXJun 10

    Current report

24. ROUTINE424B5Tango Therapeutics, Inc.TNGXJun 10

    Securities offering

25. ROUTINE144Tango Therapeutics, Inc.TNGXJun 10

    Daniella Beckman, planned sale of TNGX shares

    Daniella Beckman, reporting

26. ROUTINE4Tango Therapeutics, Inc.TNGXJun 8

    4 insider filings

    John B Ketchum, insider filing for TNGX

    Show all 4

    • 4Insider filing for TNGXJun 8
    • 4Insider filing for TNGXJun 8
    • 4Insider filing for TNGXJun 8
    • 4Insider filing for TNGXJun 8

    John B Ketchum, reporting

27. ROUTINE424B5Tango Therapeutics, Inc.TNGXJun 8

    Securities offering

28. ROUTINE8-KTango Therapeutics, Inc.TNGXJun 8

    Current report

29. ROUTINE8-KTango Therapeutics, Inc.TNGXJun 4

    Current report

30. ROUTINE4Tango Therapeutics, Inc.TNGXJun 3

    Adam Crystal, insider filing for TNGX

    Adam Crystal, reporting

31. ROUTINESCHEDULE 13G/ATango Therapeutics, Inc.TNGXMay 15

    2 13G filings

    Ownership stake disclosure by TCG Crossover GP II, LLC (amended)

    Show all 2

    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15
    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15

    TCG Crossover GP II, LLC, filed by

32. ROUTINESCHEDULE 13G/ATango Therapeutics, Inc.TNGXMay 15

    2 13G filings

    Ownership stake disclosure by Woodline Partners LP (amended)

    Show all 2

    • SCHEDULE 13G/AOwnership stake disclosure (amended)May 15
    • SCHEDULE 13GOwnership stake disclosureMay 15

    Woodline Partners LP, filed by

33. ROUTINE8-KTango Therapeutics, Inc.TNGXMay 13

    Current report

34. NOTABLE10-QTango Therapeutics, Inc.TNGXMay 13

    Quarterly report

35. ROUTINESCHEDULE 13G/ATango Therapeutics, Inc.TNGXMay 13

    Ownership stake disclosure by Adage Capital Management, L.P. (amended)

    Adage Capital Management, L.P., filed by

36. ROUTINESCHEDULE 13G/ATango Therapeutics, Inc.TNGXMay 11

    Ownership stake disclosure by Farallon Capital Partners, L.P. (amended)

    Farallon Capital Partners, L.P., filed by

37. ROUTINE8-KTango Therapeutics, Inc.TNGXMay 8

    Current report

38. ROUTINESCHEDULE 13GTango Therapeutics, Inc.TNGXMay 6

    Ownership stake disclosure by FMR LLC

    FMR LLC, filed by

39. ROUTINE4Tango Therapeutics, Inc.TNGXMay 5

    2 insider filings

    Adam Crystal, insider filing for TNGX

    Show all 2

    • 4Insider filing for TNGXMay 5
    • 4Insider filing for TNGXMay 5

    Adam Crystal, reporting

40. ROUTINESCHEDULE 13G/ATango Therapeutics, Inc.TNGXMay 4

    Ownership stake disclosure by Invus Global Management, LLC (amended)

    Invus Global Management, LLC, filed by

41. ROUTINE4Tango Therapeutics, Inc.TNGXMay 1

    Sung Lee, insider filing for TNGX

    Sung Lee, reporting

42. ROUTINE144Tango Therapeutics, Inc.TNGXMay 1

    Adam Crystal, planned sale of TNGX shares

    Adam Crystal, reporting

Older filings on EDGAR